Company Filing History:
3 out of 1,745 
1 out of 109 
Years Active: 2013-2015
Title: Innovations in Thrombosis Treatment: The Work of Julien Muzard
Introduction
Julien Muzard is a prominent inventor based in Paris, France, who has significantly contributed to the field of medical research with his groundbreaking inventions. With a total of three patents to his name, his work primarily focuses on developing innovative therapeutic solutions for thrombosis.
Latest Patents
Muzard's most noteworthy invention is the anti-glycoprotein VI single chain variable fragment (scFv 9O12.2) designed for the treatment of thrombosis. This invention consists of the variable heavy (VH) and variable light (VL) domains of the 9 O12.2.2 monoclonal antibody, which are linked through a (GlySer) peptide and followed by a 'c-myc' flag, identified as SEQ ID NO:1. The invention encompasses functional variants of this scFv fragment, which possess identical heavy and light chain complementary determining regions 1, 2, and 3. Additionally, humanized functional variants of the scFv fragments, represented by SEQ ID NO:28 or SEQ ID NO:47, have also been developed. This invention further includes the nucleic acids that encode such scFv fragments, as well as the necessary expression vectors and host cells required for their production. The therapeutic applications of these scFv fragments represent a major advancement in thrombosis treatment.
Career Highlights
Throughout his career, Julien Muzard has made significant strides in medical research. He has been associated with esteemed organizations such as INSERM (Institut National de la Santé et de la Recherche Médicale), where he engaged in high-level research that fostered innovation in the medical field. His contributions have not only advanced scientific knowledge but also paved the way for potential therapies that can improve patient outcomes.
Collaborations
Muzard's work has been enhanced through collaborations with respected colleagues, including Martine Jandrot-Perrus and Philippe Billiald. These partnerships have been instrumental in furthering research initiatives and developing new therapeutic strategies based on their combined expertise.
Conclusion
Julien Muzard exemplifies the spirit of innovation in medical research, with his developed patents offering promising solutions for the treatment of thrombosis. His dedication to advancing healthcare through science positions him as a significant figure in the world of inventors, contributing valuable insights and inventions that may change the landscape of therapeutic interventions in the future.